Peginterferon Plus Ribavirin Combination Therapy for Hepatitis C Six Months After Onset of Acute Infection
NCT02377856
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Acute Hepatitis C
Interventions
DRUG:
pegylated interferon alpha 2a, ribavirin
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital